IRD vs AMGN: Which Stock is Better?
Side-by-side comparison of Opus Genetics Inc and Amgen Inc in 2026
IRD
Opus Genetics Inc
$5.71
AMGN
Amgen Inc
$348.22
Key Metrics Comparison
| Metric | IRD | AMGN | Winner |
|---|---|---|---|
| Market Cap | $396.30M | $189.19B | AMGN |
| P/E Ratio | N/A | 24.70 | AMGN |
| EPS (TTM) | $N/A | $14.21 | AMGN |
| Revenue Growth | -0.1% | 0.1% | AMGN |
| Gross Margin | -117.0% | 70.8% | AMGN |
Analyze IRD
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IRD or AMGN a better investment?
Comparing IRD and AMGN: Opus Genetics Inc has a market cap of $396.30M while Amgen Inc has $189.19B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IRD and AMGN?
IRD (Opus Genetics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IRD or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IRD or AMGN?
AMGN has higher revenue growth at 0.1% vs -0.1% for IRD.
Which company is more profitable: IRD or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to -117.0% for IRD.
Which is the larger company: IRD or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $189.19B compared to $396.30M for IRD.
Should I buy IRD or AMGN in 2026?
Both IRD and AMGN have investment merit. IRD trades at $5.71 while AMGN trades at $348.22. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IRD and AMGN stock?
Key differences: Market Cap ($396.30M vs $189.19B), P/E Ratio (N/A vs 24.7x), Revenue Growth (-0.1% vs 0.1%), Gross Margin (-117.0% vs 70.8%).